Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...

Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...